Request permissions for this article. Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston (M.J.H., Z.S.W.). Rheumatology and ...

3 Centre de Recherche en Epidémiologie et Statistiques (CRESS), Unité Inserm 1153, Université Paris Cité, Paris, France ...

Large vessel vasculitides (LVV) comprise a group of inflammatory disorders that involve the large arteries, such as the aorta and its primary branches. The cause of LVV is often rheumatologic and ...

Apollo Radiology International (ARI) has acquired the radiology reporting unit of InHealth Group, the UK’s largest specialist provider of diagnostic and healthcare solutions. ARI, a unit of Apollo ...

Researchers evaluated the efficacy of rituximab, cyclophosphamide, or a combination of both in pediatric patients diagnosed with granulomatosis ... Registry of Childhood Vasculitis; the majority ...

Wegener's granulomatosis/granulomatosis with polyangiitis is a fatal disease if left untreated, and the natural history is for only 50% of patients to survive 5 ...

Brand and Medication Name: Rituxan, Rituximab Approved for: Treating rheumatoid arthritis, certain cancers, Pemphigus Vulgaris, Granulomatosis with Polyangitis (GPA) and Microscopic Polyangitis (MPA).